DOPATREE
Preview
Open in TheBrain
DOPATREE
DRUG SAFETY AND BIOLOGIC SAFETY / RELATED / US
EMA GOOD PHARMACOVIGILANCE PRACTICES (GVP)
EMA GOOD PHARMACOVIGILANCE PRACTICES / RELATED
EMA PHARMACOVIGILANCE PLAN (PV, DRUG SAFETY)
EMA PHARMACOVIGILANCE PLANS / RELATED
EMA PHARMACOVIGILANCE ACTIVITIES
EMA PHARMACOVIGILANCE ACTIVITIES / LISTINGS / ADDITIONAL
CLINICAL STUDIES-ALL (CLINICAL TRIALS, STUDY, PROTOCOLS, MASTER PROTOCOLS, CLINICAL OPERATIONS, CLINICAL STUDY DESIGNS, COVARIATES, CONTINUOUS OUTCOMES, ICH E8, ENRICHMENT, STUDY REPORT, HOLD, CLINICAL INVESTIGATIONS)
CLINICAL STUDIES / RELATED
Parents
CLINICAL STUDIES-ALL (CLINICAL TRIALS, STUDY, PROTOCOLS, MASTER PROTOCOLS, CLINICAL OPERATIONS, CLINICAL STUDY DESIGNS, COVARIATES, CONTINUOUS OUTCOMES, ICH E8, ENRICHMENT, STUDY REPORT, HOLD, CLINICAL INVESTIGATIONS)
Children
21 CFR PART 11 (21CFRPART11, ELECTRONIC RECORDS, ELECTRONIC SIGNATURES, 21CFR11)
ACTIVE CONTROL (INVESTIGATIONAL ARM, COMPARATOR DRUG)
BLINDING (BLINDED STUDY)
CLINICAL HOLD
CLINICAL OPERATIONS (OPERATING MODEL DESIGN, SOURCING STRATEGY, PERFORMANCE MANAGEMENT, PROCESS DESIGN, CLINICAL, FEASIBILITY, SITE SELECTION, RECRUITMENT, MONITORING, INITIATING, RESTARTING)
CLINICAL STUDY REPORT (CSR)
COMMON RULE (FEDERAL POLICY FOR THE PROTECTION OF HUMAN SUBJECTS)
COOPERATIVE RESEARCH (MULTIPLE INSTITUTIONS, MULTI-INSTITUTIONAL, ORGANIZATIONS)
DECENTRALIZED CLINICAL TRIAL (DCT, DIGITAL HEALTH TRIALS, STUDIES, STUDY, MOBILE STUDIES)
DEVELOPING COUNTRY RESEARCH (RESOURCE-LIMITED SETTINGS, RLS)
DIVERSITY IN CLINICAL TRIALS (DCT, DIVERSITY, EQUITY, INCLUSION, DE&I, GENDER, SEX, RACE, ETHNICITY, AGE)
ETHICS IN CLINICAL RESEARCH (ETHICAL BEHAVIOR, BIOETHICS)
EXTERNAL CONTROLS
GOOD CLINICAL PRACTICE (GCP, ICH E6(R2), ICH E6R2)
INSTITUTIONAL REVIEW BOARD (IRB, WAIVERS, IRB TRANSFER, CENTRALIZED REVIEW, MULTICENTER, INSPECTIONS, CENTRAL IRB, SINGLE IRB)
MULTI-REGIONAL CLINICAL STUDIES (MULTI-COUNTRY, MULTIPLE COUNTRIES)
PATIENT-REPORTED OUTCOMES (PROS, PATIENT, REPORTED)
PEDIATRIC STUDY PLAN (PSP, PEDIATRIC INVESTIGATION PLANS, PIP, PEDIATRIC RESEARCH EQUITY ACT, PREA, BEST PHARMACEUTICALS FOR CHILDREN ACT, BPCA, CLINICAL STUDIES, PEDIATRIC AGE GROUP, NEONATAL)
PLACEBO (SUGAR PILL, PLACEBO CONTROL, COMPARATOR)
PROTOCOL DEVELOPMENT (CLINICAL STUDY DESIGNS, ENDPOINTS, CLINICAL TRIALS, NON-INFERIORITY, SUPERIORITY, NONINFERIORITY, COHORTS, EFFICACY, SAFETY, EFFECTIVENESS)
QUALITY ASSURANCE (QA, GGXP COMPLIANCE AUDITS, INVESTIGATOR SITE, VENDOR, FOR CAUSE, TMF, DATABASE, COMPLIANCE, SAFETY/ PV, CENTRAL LAB, GMP, QUALITY MANAGEMENT SYSTEM, QMS, CAPA, TRAINING, SOP)
REMOTE DATA CAPTURE (REMOTE DATA ACQUISITION)
RISK-BASED MONITORING (RBM, INTEGRATED QUALITY RISK MANAGEMENT, IQRM)
SPECIAL PROTOCOL ASSESSMENT (SPA)
STUDY NETWORKS-ALL (CLINICAL TRIAL NETWORKS, CTN, CLINICAL STUDY NETWORKS, EUROPEAN REFERENCE NETWORKS, ERN, RESEARCH, CLINICAL RESEARCH NETWORKS, CRN)
STUDY REGISTRATION (TRIAL TRANSPARENCY, PROTOCOL REGISTRATIONS, RESULTS POSTING, REGISTRIES, STATISTICAL XML SUPPORT, CLINICALTRIALS.GOV, POLICY 70, LAY SUMMARY, FORM FDA 3674, CLINICALTRIALSREGISTER, CLINICAL STUDIES)
STUDY SCREENING TESTS
STUDY SUBJECT (PATIENT, PARTICIPANT, TRIAL, HUMAN SUBJECT)
SYNTHETIC CONTROLS (EXTERNAL CONTROLS)
TRIAL MASTER FILES (TMF, STUDY MASTER FILES, SITE STUDY FILES)